Each year WK Sports Medicine offers free physical exams for high school athletes and eighth-grade student athletes entering high school in the fall. These exams were provided by 20 doctors from Willis-Knighton Health System and LSU Health Shreveport as well as 15 physical therapists, 10 athletic trainers and students from the Physical Therapy Assistant program at Bossier Parish Community College.
Christopher Shelby, MD, of WK Eye Institute has successfully performed the area’s first surgery to implant a miniature telescope in the eye of a patient with end-stage macular degeneration.
Willis-Knighton has received Full Chest Pain Center with Primary PCI Accreditation from the Society of Cardiovascular Patient Care (SCPC). Willis-Knighton is the only local facility that has achieved this designation.
Willis-Knighton Cancer Center is now offering Optune, a medical device that, when used in conjunction with partial-brain radiotherapy and chemotherapy, has been shown to extend overall survival and progression-free survival of newly diagnosed patients with glioblastoma multiforme (GBM). Optune is a portable, noninvasive device that delivers low-intensity, alternating electric fields (referred to as Tumor Treating Fields) that inhibit cancer cell replication and cause cancer cells to die.
Willis-Knighton was pleased to learn that the Caddo Parish School Board has accepted its bid for the Hamilton Terrace school property.
In January Willis-Knighton Cancer Center joins leading cancer centers in the United States in a new research initiative evaluating two types of radiation therapy approved by the U.S. Food & Drug Administration for the treatment of breast cancer.
The Willis-Knighton Cancer Center has added cone beam computed tomography (CBCT) to its ProteusONE compact proton therapy solution. This is the first FDA approved CBCT for compact proton therapy to be used for treatment of a breast cancer patient.
WK Eye Institute surgeons Christopher Shelby, MD, and Wyche T. Coleman III, MD, are the first in our region to offer the iStent® Trabecular Micro-Bypass Stent as a treatment option to reduce eye pressure for patients who have both cataracts and glaucoma.
Willis-Knighton Heart & Vascular Institute at Willis-Knighton Medical Center is the first location in the region to participate in the Abiomed Mobile Learning Lab (MLL) program. The Abiomed Mobile Learning Lab will be parked at Willis-Knighton Medical Center on Friday, Oct. 30, where it will offer a highly interactive, facilitated learning experience to physicians and staff interested in learning about the Impella heart pump.
Please click the link above to read the statement